Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)

This publication has 27 references indexed in Scilit:

• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells
  Oncogene, 1999
• TRAIL: a molecule with multiple receptors and control mechanisms
  Current Opinion in Immunology, 1998
• Inhibition of Nuclear Factor κB Activation Attenuates Apoptosis Resistance in Lymphoid Cells
  Blood, 1998
• Apoptosis Induction by Caspase-8 Is Amplified through the Mitochondrial Release of Cytochrome c
  Journal of Biological Chemistry, 1998
• Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD‐specific caspase activation and independently of mitochondrial transmembrane depolarization
  The EMBO Journal, 1998
• The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
  Immunity, 1997
• Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
  Journal of Experimental Medicine, 1997
• Mitochondrial control of apoptosis
  Immunology Today, 1997
• Ewing’s Sarcoma
  1992